SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elisabetta Tronci, Camino Fidalgo, Manolo Carta, Foetal Cell Transplantation for Parkinson’s Disease: Focus on Graft-Induced Dyskinesia, Parkinson's Disease, 2015, 2015, 1

    CrossRef

  2. 2
    Flavia Niccolini, Lorenzo Rocchi, Marios Politis, Molecular imaging of levodopa-induced dyskinesias, Cellular and Molecular Life Sciences, 2015, 72, 11, 2107

    CrossRef

  3. 3
    Marios Politis, Flavia Niccolini, Serotonin in Parkinson's disease, Behavioural Brain Research, 2015, 277, 136

    CrossRef

  4. 4
    F. Niccolini, C. Loane, M. Politis, Dyskinesias in Parkinson's disease: views from positron emission tomography studies, European Journal of Neurology, 2014, 21, 5
  5. 5
    Janelle Drouin-Ouellet, The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease, Neurodegenerative Disease Management, 2014, 4, 4, 297

    CrossRef

  6. 6
    Karoline Wenzel, Carl Nikolaus Homann, Giovanni Fabbrini, Carlo Colosimo, The role of subcutaneous infusion of apomorphine in Parkinson’s disease, Expert Review of Neurotherapeutics, 2014, 14, 7, 833

    CrossRef

  7. 7
    Olle Lindvall, Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?, Movement Disorders, 2013, 28, 3
  8. 8
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki, α-Synuclein and Neuronal Cell Death, Molecular Neurobiology, 2013, 47, 2, 466

    CrossRef

  9. 9
    Neil Issar, Joseph Neimat, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  10. 10
    Neil M. Issar, Joseph S. Neimat, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  11. 11
    Kathy Steece-Collier, David J. Rademacher, Katherine E. Soderstrom, Anatomy of graft-induced dyskinesias: Circuit remodeling in the parkinsonian striatum, Basal Ganglia, 2012, 2, 1, 15

    CrossRef

  12. 12
    J. Guridi, R. González-Redondo, J. A. Obeso, Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  13. 13
    Ying Xia, Chengchuan Jiang, Zuowei Cao, Keshan Shi, Yang Wang, Co–transplantation of macaque autologous Schwann cells and human embryonic nerve stem cells in treatment of macaque Parkinson's disease, Asian Pacific Journal of Tropical Medicine, 2012, 5, 1, 7

    CrossRef

  14. 14
    C. Warren Olanow, Ole Isacson, Stem cells for Parkinson's disease: Advancing science but protecting patients, Movement Disorders, 2012, 27, 12
  15. 15
    Amanda L. Piquet, Kala Venkiteswaran, Neena I. Marupudi, Matthew Berk, Thyagarajan Subramanian, The immunological challenges of cell transplantation for the treatment of Parkinson's disease, Brain Research Bulletin, 2012, 88, 4, 320

    CrossRef

  16. 16
    Iciar Aviles-Olmos, Zinovia Kefalopoulou, Thomas Foltynie, Understanding and Prevention of “Therapy-” Induced Dyskinesias, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  17. 17
    Jonathan R. Evans, Sarah L. Mason, Roger A. Barker, Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I, 2012,

    CrossRef

  18. 18
    Alison K. Hall, Robert H. Miller, Basic Neurochemistry, 2012,

    CrossRef

  19. 19
    Emma L. Lane, Christian Winkler, Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I, 2012,

    CrossRef

  20. 20
    Jörg B. Schulz, Manfred Gerlach, Gabriele Gille, Wilfried Kuhn, Martina Müngersdorf, Peter Riederer, Martin Südmeyer, Albert Ludolph, Basic science in Parkinson’s disease: its impact on clinical practice, Journal of Neurology, 2011, 258, S2, 299

    CrossRef

  21. 21
    Dustin R. Wakeman, Hemraj B. Dodiya, Jeffrey H. Kordower, Cell Transplantation and Gene Therapy in Parkinson's Disease, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 1
  22. 22
    Joanna García, Thomas Carlsson, Máté Döbrössy, Guido Nikkhah, Christian Winkler, Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation, Experimental Neurology, 2011, 232, 2, 270

    CrossRef

  23. 23
    Marios Politis, Wolfgang H. Oertel, Kit Wu, Niall P. Quinn, Oliver Pogarell, David J. Brooks, Anders Bjorklund, Olle Lindvall, Paola Piccini, Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio, Movement Disorders, 2011, 26, 11
  24. 24
    Ron L. Alterman, Michele Tagliati, C. Warren Olanow, Open-label surgical trials for Parkinson disease: Time for reconsideration, Annals of Neurology, 2011, 70, 1
  25. 25
    Marios Politis, Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease, BMC Medicine, 2011, 9, 1, 50

    CrossRef

  26. 26
    T.B. Freeman, F. Cicchetti, A.C. Bachoud-Lévi, S.B. Dunnett, Technical factors that influence neural transplant safety in Huntington's disease, Experimental Neurology, 2011, 227, 1, 1

    CrossRef

  27. 27
    Dalton James Surmeier, Jaime N. Guzman, Javier Sanchez-Padilla, Joshua A. Goldberg, The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies, Antioxidants & Redox Signaling, 2011, 14, 7, 1289

    CrossRef

  28. 28
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  29. 29
    Emma L. Lane, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  30. 30
    M. Politis, K. Wu, C. Loane, N. P. Quinn, D. J. Brooks, S. Rehncrona, A. Bjorklund, O. Lindvall, P. Piccini, Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants, Science Translational Medicine, 2010, 2, 38, 38ra46

    CrossRef

  31. 31
    EL Lane, GA Smith, Understanding graft-induced dyskinesia, Regenerative Medicine, 2010, 5, 5, 787

    CrossRef

  32. 32
    Emma L. Lane, Anders Björklund, Stephen B. Dunnett, Christian Winkler, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  33. 33
    Emma Louise Lane, Patrik Brundin, M. Angela Cenci, Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease, Neurobiology of Disease, 2009, 35, 1, 42

    CrossRef

  34. 34
    C. Warren Olanow, Jeffrey H. Kordower, Anthony E. Lang, Jose A. Obeso, Dopaminergic transplantation for parkinson's disease: Current status and future prospects, Annals of Neurology, 2009, 66, 5
  35. 35
    Livia Dézsi, László Vécsei, Established therapies and novel targets in the treatment of Parkinson’s disease, Expert Review of Clinical Pharmacology, 2009, 2, 6, 631

    CrossRef

  36. 36
    Lachlan H. Thompson, Anders Björklund, Neurotherapy: Progress in Restorative Neuroscience and Neurology, 2009,

    CrossRef

  37. 37
    S. Elizabeth Zauber, Christopher G. Goetz, Dyskinesias in Parkinsonian Syndromes,